t

AI Summary

BioPharma Credit PLC announced its unaudited net asset value per Ordinary Share, including current period revenue, as 100.48 cents. This value was reported as at 31 May 2026 and the announcement was dated 19 June 2026.

RNS Metadata

/Equities/XLON/BPCR/RNS

Net Asset Value(s) and Monthly Factsheet

RNS Number : 0266J

BioPharma Credit PLC

19 June 2026

BIOPHARMA CREDIT PLC (the 'Company')
 
As at the 31 May 2026 the unaudited net asset value per Ordinary Share, including current period revenue, was 100.48 cents. The Company's factsheet will be located on the Company's website, http://bpcruk.com.
 
Dated: 19 June 2026
 
Legal Entity Identifier 213800AV55PYXAS7SY24

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NAVFLMPTMTJBMFF

TIDM	BPCR
Share Price	US$72.40-2.19%
Market Cap	$99.47bn

TIDM	BPCR
Share Price	US$72.40-2.19%
Market Cap	$99.47bn

t

Company Information

AI Summary

RNS Metadata

Net Asset Value(s) and Monthly Factsheet

Company Information

AI Summary

RNS Metadata